ArticleIntervirology2022

Evaluation of IL-1β and IL-6 Expression following EBNA-1 and BRLF-1 Peptide Treatment in Epstein-Barr Virus-Positive Multiple Sclerosis Patients.

Roya Kianfar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.